Download - SHM: Monitoring of HIV in the Netherlands

2

SHM: Monitoring of HIV in the Netherlands

Frank de Wolf, Ard van Sighem

• Aim• Data collection• Analysis en reporting• Results• Conclusions

3

Aim SHM

• Contribute to knowledge of HIV in the Netherlands through study of:– The course of infection in people with HIV– The effect of treatment of people with HIV

4

Actual practice


• We monitor the treatment of each and every man or woman with HIV in the Netherlands

• We map out the HIV epidemic in the Netherlands

5

Stakeholders


• We monitor the treatment of each and every man or woman with HIV in the Netherlands

• We map out the HIV epidemic in the Netherlands• Individuals with HIV• Treating physicians• HIV care policy makers• HIV researchers

6

How

Per HIV Treatment Centre:• Collection of data from all people with HIV in care• In collaboration with the HIV-treating physician, who

supervises the actual collection of data from patients for whom he provides HIV care

• 26 hospitals throughout thecountry are acknowledgedby the Ministry of Healthas HIV treatment Centre

7

Data collection: 5 steps

8

Step 1: Registration and Entry

SHM enrolment database

Enrolment- /discontinuation form

Clinical laboratories

Patient’s medical file

Treating physician

Other laboratories

Routine patient care

Patient

Diagnostic procedures

Data collection & QC Data storage & analysis

Material

9

Step 2: Monitoring ID code or M number

Data collectors


Fax: ID code = ‘M-number’


National SHM database



Treating physician

Other laboratories


Patient

Material



10

Step 3: Collection of patient data

Data collectors







Treating physician

Other laboratories


Patient

Material



11

Step 4: Data Quality Control

Data collectors







Treating physician

Other laboratories


Patient

Material



Data monitors

12

Step 5: Data preparation and analysis

Data collectors





SHM researchers



An

alys

is

Treating physician

Other laboratories

Discrepancies


Patient

Material



Monitoring Report & Research output

Data monitors

13

Computerisation

Data collectors





SHM researchers



An

alys

is

Treating physician

Other laboratories

Discrepancies


Patient

Material



Monitoring Report & Research output

Data monitors

14

Analysis and Reporting

15

Individual patient reporting

16

Reporting per Treatment Centre

17

National Reporting

18

International Reporting

19

International Reporting

2011: 40 papers

20

Results

21

Cascade of HIV care

22

Effect of antiretroviral treatment of people with HIV

Gras L, et al; J Acquir Immune Defic Syndr 45 ( 2) 2007

Gras L, et al; Monitoring Report 2011, Stichting HIV Monitoring, Amsterdam, November 2011

23

Effect of treatment on the course of the HIV epidemic

status quo N=1470

annual testing N=629

immediate cART N=917

reduced risk N=139

Bezemer et al, AIDS (2008); Van Sighem et al (2011)

24

Effect of PrEP on the number of new HIV infections

No PrEP New MSM

All MSM5%

All MSM10%

New MSM + 5% all MSM

# in

fecti

on

s 2

010-2

019

0

2000

4000

6000

8000

10000

28%33%

46% 45%

Van Sighem A, et al. State of the cART (2012)

25

Increasing plasma HIV-RNA over time

26

0

500

1000

1500

2000

2500

3000

3500

4000

1998199920002001200220032004200520062007200820092010

calendar year

abso

lute

num

ber

0

5

10

15

20

25

30

35

40

%

Total HCV Ab positive

total HCV Ab tests

percentage postive

HCV seroconverters

New HCV diagnoses amongst HIV-infected patients

• Increase in HCV testing• Increase in number HCV

positives with a last HCV negative test result

• Percentage positive declined to 4% per year

• Percentages tested positive for HCV declined (stratified by risk group)

0

5

10

15

20

25

30

1998 2000 2002 2004 2006 2008 2010

calendar year

perc

enta

ge

MSM

Other HIV risk group

Smit C, et al. AIGHD HCV Symposium (2012)

27

Conclusions

28

HIV monitoring is a must

• HIV Monitoring is crucial for assessing the quality of care for people with HIV, including the effect of antiretroviral treatment and the development of resistance

• HIV monitoring is needed for our understanding of the changes in the HIV epidemic

• Mandatory collection of anonymised patient data is essential for HIV monitoring

29

SHM

Patient data collection and QCManager: Sima Zaheri

Patient Registration: Rosalind Beard

Data Collection: Mieke van den Akker, Yvonne Bakker, Marjo Broekhoven-van Kruijne, Els Claessen, Chantal Deurloo-van Wanrooij, Leonie de Groot-Berndsen, Carla Lodewijk, Brid Peeck, Yolanda Ruijs-Tiggelman, Els Tuijn-de Bruin, Lia Veenenberg-Benschop, Tieme Woudstra.

Data Monitoring & QC: Marieke Berkhout, Rosalie van den Boogaard, Shula Grivell, Mariska Hillebregt, Pytsje Hoekstra, Anna Jansen, Viola Kimmel, Anna de Lang, Bianca Slieker, Nynke Wijnstok

Data preparation and analysisHead: Frank de WolfResearch staff: Daniela Bezemer, Luuk Gras, Ard van Sighem, Colette Smit, Rebecca Holman Anouk Kesselring, PhD students: Esther Engelhard, Gonneke Hermanides, Rob van den Hengel

Office, Administration, CommunicationManager: Danielle de BoerOffice: Mireille Koenen, Inge BartelsAdministration: Irene de Boer, Henk van NoortCommunication: Louise Dolfing-Tompson, Anneke Nollen

DirectorFrank de Wolf